• SENSEX 73,055.43
    -193.96 (--0.26%)
  • BANKNIFTY 54,925.70
    -51.20 (--0.09%)
  • SBI
    950.75 900.80(%)
  • Cyient
    1,268.00 1,226.25(%)
  • NSE
    1,640.25 1,683.00(%)
  • JSW Energy
    440.25 428.00(%)
  • Voltas
    940.00 970.70(%)
  • Eternal
    317.50 344.75(%)
  • IndusInd Bank
    832.00 750.45(%)
  • Persistent Systems
    5,909.85 6,597.00(%)
  • Swiggy
    174.90 207.75(%)
  • Cupid
    302.45 45.40(%)
  • TCS
    2,624.75 3,336.70(%)
  • Infosys
    1,198.30 1,727.85(%)
  • Havells India
    1,003.65 1,015.20(%)
  • C P C L
    1,529.95 1,677.00(%)
  • Lenskart Solut.
    615.80 355.70(%)
  • Divi's Lab.
    8,800.00 5,648.00(%)
  • PC Jeweller
    17.08 7.45(%)
  • Steel Str. Wheel
    469.70 434.05(%)
  • Reliance Industries
    1,201.95 1,611.20(%)
  • Netweb Technol.
    4,238.00 2,942.45(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Lupin Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 3026.0
  • ISIN : INE326A01037
1,922.00 -42 (-2.14%)
  • As on 23 Oct 2026 (EOD)

  • Today’s Low

    1,896.10

  • Today’s High

    1,945.70

  • Open

    1,942.00

  • Perv Close

    1,964.00

  • 52W Low

    1,896.10

  • 52W High

    2,529.50

Key Indicators

  • P/E(TTM)

    13.31

  • Mar.Cap (₹Cr.)

    87,891.13

  • Div & Yield %

    0.93

  • Book Value(₹)

    658.96

  • Debt-Equity Ratio

    -2.14

  • AGM Date

    22-Oct-2026

  • EPS

    144.80

  • P/E Ratio

    13.31

Financials Ratios

  • Debt-Equity Ratio

    0.28

  • Mar.Cap (₹Cr.)

    87,891.13

  • RONW (%)

    14.47

  • ROCE (%)

    15.34

Score Board

  • Equity (₹ in Cr.)

    91.46

  • BV (₹)

    659.00

  • Sales( ₹ in Cr.)

    19,512.66

  • NP (in Cr.)

    5,774.01

  • NP Var(%)

    44.0

  • Div%

    900.0

  • CPS (₹)

    141.70

  • EPS (₹)

    126.30

  • Traded Value (₹ in Lakhs)

    88,165.51

  • 52 Week High

    2,529.50

  • 52 Week Low

    1,896.10

  • Price BSE

    1928.0

  • Price NSE

    1,922.00

  • Market Capital( in Cr.)

    88,165.51

  • P/C Ratio

    13.60

  • P/E Ratio

    15.30

  • Price Vs.BV

    126.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 19,512.66 16,967.50 14,666.50 11,258.83 11,771.67 11,055.93
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 19,512.66 16,967.50 14,666.50 11,258.83 11,771.67 11,055.93
Other Income 1,346.44 253.39 115.51 210.02 216.99 129.09
Stock Adjustments -4.66 38.35 15.93 -120.79 242.38 81.86
Total Income 20,854.44 17,259.24 14,797.94 11,348.06 12,231.04 11,266.88
EXPENDITURE :            
Raw Materials 4,870.68 4,963.57 5,041.16 4,676.90 4,709.64 4,264.17
Power and Fuel Cost 385.66 414.63 444.41 447.42 418.45 389.54
Employee Cost 2,544.88 2,312.07 2,095.51 1,934.14 1,918.16 1,695.86
Other Manufacturing Expenses 1,591.55 1,268.19 1,182.52 1,155.60 1,209.09 1,135.79
Selling and Administration Expenses 2,745.98 2,352.64 2,264.54 1,797.13 1,573.22 1,355.01
Miscellaneous Expenses 192.79 378.83 204.01 162.95 1,976.35 253.36
Employee Benefit Expenses 2,544.88 2,312.07 2,095.51 1,934.14 1,918.16 1,695.86
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 12,331.54 11,689.93 11,232.15 10,174.14 11,804.91 9,093.73
Operating Profit 8,522.90 5,569.31 3,565.79 1,173.92 426.13 2,173.15
Interest 121.47 84.50 56.35 98.44 73.47 40.62
Gross Profit 8,401.43 5,484.81 3,509.44 1,075.48 352.66 2,132.53
Depreciation 707.18 647.69 724.75 548.34 514.19 502.83
Profit Before Tax 7,694.25 4,837.12 2,784.69 527.14 -161.53 1,629.70
Current Tax 1,351.29 857.12 484.05 95.89 57.80 362.85
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -23.60 7.04 -25.45 6.04 -30.63 8.23
Reported Net Profit 6,366.56 3,972.96 2,326.09 425.21 -188.70 1,258.62
Extraordinary Items 592.55 -27.20 23.78 14.42 30.64 41.61
Adjusted Net Profit 5,774.01 4,000.16 2,302.31 410.79 -219.34 1,217.01
Adjustment below Net Profit 4.02 -4.11 -8.79 -1.39 2.42 -7.89
P & L Balance brought forward 20,913.45 17,333.97 15,274.71 15,032.74 15,514.10 14,535.25
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 569.93 389.37 258.04 181.85 295.08 271.88
P & L Balance carried down 26,714.10 20,913.45 17,333.97 15,274.71 15,032.74 15,514.10
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 900.00 600.00 400.00 200.00 200.00 325.00
Dividend Per Share(Rs) 18.00 12.00 8.00 4.00 4.00 6.50
Earnings Per Share-Unit Curr 139.25 87.01 51.04 9.35 -4.15 27.74
Earnings Per Share(Adj)-Unit Curr 139.25 87.01 51.04 9.35 -4.15 27.74
Book Value 659.09 531.72 452.12 404.66 399.34 409.20
Book Value(Adj)-Unit Curr 659.09 531.72 452.12 404.66 399.34 409.20

Shareholding Pattern

  • Promoter Group

    46.85%

  • Public Share Holding

    53.16%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 1,286,394 1,286,394.00 1,286,394 1,286,394
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 1,286,394 0.28 1,286,394 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 207,194,390 45.31 207,194,390 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 5,735,590 1.25 5,735,590 7
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 1,000 0.00 1,000 1
Others 0 0.00 0 0
Sub Total 212,930,980 46.56 212,930,980 9
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 9,711 0.00 9,711 2
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 494,344 0.11 492,944 11
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 106,460,781 23.28 106,460,781 903
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 29,196,440 6.38 29,196,440 26
Mutual Funds / UTI 66,668,776 14.58 66,666,176 43
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 12,397,852 2.71 12,397,852 20
Trusts 2,679 0.00 2,679 6
Venture Capital Funds 0 0.00 0 0
Sub total 215,230,583 47.07 215,226,583 1,011
2] Non Institution
Bodies Corporate 1,338,121 0.29 1,333,321 1,143
Clearing Members 56,131 0.01 56,131 56
Directors of their Relatives 2,000 0.00 2,000 1
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 5,000 0.00 5,000 1
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 1,485,254 0.32 1,484,854 8,967
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 548,458 0.12 548,458 4,204
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 618,169 0.14 618,169 4
Individuals holding nominal share capital up to Rs. 1 lakh 22,838,660 4.99 22,428,329 281,827
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 117,262 0.03 117,262 17
Others 769,651 0.17 769,651 1
Sub Total 27,842,015 6.09 27,426,484 296,278
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 457,289,972 100.00 456,870,441 297,301

Company Background

Lupin LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Lupin Ltd
  • BSE Code : 3026.0
  • ISIN : INE326A01037

  • Incorporation Year

    1983

  • Registered Office

    Kalpataru Inspire 3rd Floor
    Off Western Exp HW Santacruz-E, Mumbai,
    Maharashtra-400055

  • Telephone

    91-22-6640 2323

  • FAX

    91-22-6640 8131

  • Chairman

    M D Gupta

  • Managing Director

    Nilesh Gupta

  • Company Secretary

    Amit Kumar Gupta.

  • Auditor

    B S R & Co LLP/Deloitte Haskins & Sells LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    MUFG Intime India Pvt Ltd
    C-101 247 Park,
    L B S Marg,Vikhroli West
    Mumbai - Mumbai-400083

Lupin Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Lupin 1,928.00 20,452.53 19,512.66 12.68 27.47
Abbott India 25,393.50 7,217.19 6,929.05 33.42 43.78
Astrazeneca Phar 6,098.65 2,304.07 2,275.58 89.88 27.86
Glaxosmi. Pharma 2,434.70 3,932.76 3,790.20 38.89 58.17
Novartis India 1,686.70 393.10 354.33 42.59 15.94
Cipla 1,329.90 20,102.60 18,979.95 34.95 13.88
Bliss GVS Pharma 640.25 773.53 729.81 59.50 12.51
Amrutanjan Healt 495.80 520.13 502.55 26.56 24.16
Fermenta Biotec. 457.40 474.15 450.25 21.35 18.77
Guj. Themis Bio. 355.10 168.25 165.82 94.95 18.05
Ambalal Sarabhai 36.28 19.52 3.94 67.19 6.77